Join the Leaders in Advanced Anti-Aging Medicine

Module VII: Inflammaging and Autoimmunity: A Revolution in Assessment and Treatment. More than 50 million Americans now suffer from one or more autoimmune illness and 80% are women. Thirty years ago, only one in 400 people developed an autoimmune illness but today, one in 12 Americans and one in nine women are diagnosed with an autoimmune illness. Currently we have 100+ autoimmune disorders all caused by the common thread of autoimmunity.

This module will focus on the adaptive immune system dysregulation and autoimmune disease, inflammaging and metaflammation and drivers of system wide inflammation. We will review a system’s biology approach to assessment and treatment of chronic inflammation that lead to a variety of clinical syndromes such as chronic fatigue, fibromyalgia, rheumatoid arthritis, lupus, and neurodegenerative disorders. Cellular and molecular biology of immunity, the cellular stress response, oxidation, genetic damage, inflammation, etiology of disease including environmental and lifestyle factors, and the risk for cancer development are also reviewed. Additionally, we will review innovative treatment options in autoimmune illness and ways to modulate inflammation with low dose naltrexone as well as other botanicals.

Objectives

  • Identify the role of the adaptive immune system in autoimmune disease
  • Recognize the intracellular signaling pathways, cellular biology, and molecular biology of immunity and inflammation including the cell danger response and development of CIRS
  • Describe the important interactions of metabolic disorders as drivers of inflammation
  • Review innovation in the treatment of RA, Lupus and IBD
  • Review neurodegenerative disorders and ways combat
  • Compare integrative oncology protocols and immune nutritional support techniques
  • Describe the role of resolvins, protectins and other mediators in reversing the inflammatory cascade
  • Describe the role of gut dysregulation and its role in autoimmunity
  • Review the role of Low Dose Naltrexone in the treatment of Autoimmune disorders
  • Review the role of botanicals and other innovative substances in the treatment of systemic inflammation
Show More

Schedule (Schedule Subject to Change)All times are in ET

Friday, November 19, 2021

8:00 am
Autoimmune Disease: Adaptive Immune System Review
Joseph A. Bellanti, MD
10:00 am
Break
10:15 am
Inflammaging- The Role of Immunosenescence in Chronic Disease
TBD
11:15 am
Lunch
11:45 am
How the Gut Microbiota influences Metabolic Resiliency, Immunocompetence and Biotransformation
Thomas Guilliams, PhD
3:30 pm
Break
4:00 pm
Psycho-Neuro-Immunology - The New Frontier
Jennifer M. Loftis, PhD
5:30 pm
Hormonal Effects on Immune Regulation and Ways to Balance
TBD
6:00 pm
Close of Session

Saturday, November 20, 2021

8:00 am
Disorders Involving Inflammation and Natural Treatments: From COVID-19 to Autism Spectrum Disorder
Theoharis C. Theoharides, MS, MPhil, PhD, MD, FAAAAI
10:00 am
Break
10:15 am
Combatting Neurodegeneration
Terry Wahls, MD
12:15 pm
Lunch
12:45 pm
Cancer- Immune Dysregulation and Novel Treatment Approach
Mark Rosenberg, MD
2:45 pm
Break
3:00 pm
Systemic Lupus Erythematosus (SLE)
TBD
4:00 PM
RA, Osteoarthritis
George Munoz, MD
5:00 pm
Close of Session

Sunday, November 21, 2021

8:00 am
The Mouth - Where Health or Disease Originate
TBD
9:00 am
Pro-Resolving Mediators
Sara Gottfried, MD
10:00 am
Break
10:15 am
Low Dose Naltrexone: Exciting Clinical Applications
Sahar Swidan, PharmD, BCPS, FMNM, ABAAHP
11:15 am
Herbals/Supplements in Immune Modulation
Sahar Swidan, PharmD, BCPS, FMNM, ABAAHP
12:15 pm
Lunch
12:45 pm
Regenerative Therapies in Autoimmune Disorders
TBD
2:45 pm
Break
3:00 pm
Immunomodulatory Supplements and Peptides: The New Frontier
James LaValle, RPh, CCN
4:00 pm
Patient Cases – Connecting All the Dots
James LaValle, RPh, CCN
5:00 pm
Close of Session

Registration

Module VII: Clinical Strategies to Optimize Metabolic Resiliency, Immunocompetence and Biotransformation (Part B)
Physician
$2500
Allied Health
$2250